Pharmaceutical company AstraZeneca is aiming to produce 2 billion doses of a coronavirus vaccine, including 400 million for the U.S. and U.K. and 1 billion for those in low- and middle-income countries.
It plans to start distributing the vaccine to the U.S. and U.K. in September or October, with the balance of deliveries likely to be made by early 2021, according to AstraZeneca CEO Pascal Soriot, on a call with journalists Thursday.
www.cnbc.com
--
They are so confident in this vaccine that they are developing for the public while trials and testing are taking place.
It plans to start distributing the vaccine to the U.S. and U.K. in September or October, with the balance of deliveries likely to be made by early 2021, according to AstraZeneca CEO Pascal Soriot, on a call with journalists Thursday.
AstraZeneca is aiming to produce 2 billion doses of a coronavirus vaccine â and it could be ready by September
The pharmaceutical company aims to distribute 1 billion shots to people in low and middle income countries, with 400 million doses ready this year.
www.cnbc.com
They are so confident in this vaccine that they are developing for the public while trials and testing are taking place.
